Design and synthesis of beta-site amyloid precursor protein cleaving enzyme (BACE1) inhibitors with in vivo brain reduction of beta-amyloid peptides.
Swahn, B.M., Kolmodin, K., Karlstrom, S., von Berg, S., Soderman, P., Holenz, J., Berg, S., Lindstrom, J., Sundstrom, M., Turek, D., Kihlstrom, J., Slivo, C., Andersson, L., Pyring, D., Rotticci, D., Ohberg, L., Kers, A., Bogar, K., von Kieseritzky, F., Bergh, M., Olsson, L.L., Janson, J., Eketjall, S., Georgievska, B., Jeppsson, F., Falting, J.(2012) J Med Chem 55: 9346-9361
- PubMed: 22924815 
- DOI: 10.1021/jm3009025
- Primary Citation of Related Structures:  
4B00, 4AZY - PubMed Abstract: 
The evaluation of a series of aminoisoindoles as β-site amyloid precursor protein cleaving enzyme 1 (BACE1) inhibitors and the discovery of a clinical candidate drug for Alzheimer's disease, (S)-32 (AZD3839), are described. The improvement in permeab ...